KPET ULTRA PACELINE COR-CL A

KPETNYSE

🏆 #2979 by market capUS Equity

$9.99▼ $0.06 (−0.60%)

Live

1h—

24h▼ 0.6%

7d▲ 0.0%

14d▲ 0.0%

30d—

1y—

🏦Market Cap

$287M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Fair

Trading Snapshot

Day Range: $9.85 – $10.08
52-Week Range: $9.91 – $10.21
Volume: $3.18B
Avg Volume: $2.44B
Shares Outstanding: 28.8M
Next Earnings: Oct 19, 2026

Fundamentals Snapshot

Annual Revenue: $22M
Last Q Revenue: $6M
P/E Ratio: —
P/S Ratio: —
EPS (TTM): —
Dividend Yield: —

Why Investors Own KPET

✓High-growth profile — revenue up +12.3% YoY with expanding US Equity exposure.
✓Healthy economics — 36% gross margin and 24% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$22M▲ +13.3% YoY

Gross Margin (TTM)

36.4%▲ +2.5% YoY

Operating Income (TTM)

$3M▲ +13.3% YoY

Free Cash Flow (TTM)

$5M▲ +13.3% YoY

About KPET ULTRA PACELINE COR-CL A

KPET Ultra Paceline Corporation primarily aims to complete a strategic business combination. This includes initiatives such as mergers, consolidations, share swaps, asset acquisitions, or corporate restructurings involving one or more other enterprises. The company was established in 2025 and operates from Sioux Falls, South Dakota.

🦦